Procter & Gamble Hygiene & Health Care Ltd. Revenue Breakdown – NSE:PGHH
NiveshIQ
NSE: PGHH · Healthcare
Procter & Gamble Hygiene & Health Care Ltd.
₹8,477.00▼ ₹121.50 (-1.41%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on PGHH. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Procter & Gamble Hygiene & Health Care Ltd.
Procter & Gamble Hygiene and Health Care Limited (PGHH) is a leading player in the Indian consumer defensive sector, with a diversified portfolio of fast-moving consumer goods. The company operates through two segments: Health care Products and Hygiene Products, offering a wide range of products including ointments, creams, cough drops, tablets, feminine hygiene products, baby care products, grooming products, laundry products, hair care products, and oral care products. PGHH sells its products under well-established brands such as Vicks, Whisper, Pampers, Ariel, Tide, Gillette, Head & Shoulders, and Oral-B. The company generates significant revenue from its feminine care and baby care products, with Whisper being one of the leading brands in the Indian feminine care market. In FY23, PGHH
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹3,905 Cr +3.00% | ₹4,192 Cr +7.30% | ₹4,290 Cr +2.40% |
| EBITDA Margin | 23.28% | 24.40% | 28.28% |
| Net Profit | ₹678.14 Cr +17.80% | ₹675.02 Cr -0.50% | ₹856.50 Cr +26.90% |
| EPS | ₹208.91 | ₹207.95 | ₹263.86 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Price to earnings forward of Procter & Gamble Hygiene & Health Care Ltd. – NSE:PGHH
PGHH saves ₹86 crore, PAT rises 19% on flat sales
🔒
+ 1 more stories about Procter & Gamble Hygiene & Health Care Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q1FY27 results: revenue ₹891 Cr, PAT ₹126 Cr, EPS ₹38.90, EBITDA margin 20.1%. Growth context: revenue QoQ -5.3%, PAT QoQ -17.5%. Street verdict: strong miss, revenue surprise -11.4%, PAT surprise -32.5%.
Volume growth, premiumisation, distribution reach, same-store throughput, and gross-margin discipline remain the key for...
FY26 (last completed FY): revenue ₹4, 290 Cr, PAT ₹856 Cr, EBITDA margin 28.3%, EPS ₹263.86. Year-on-year: revenue YoY +...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for PGHH
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track PGHH alongside your other holdings
Unlock full PGHH research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Procter & Gamble Hygiene & Health Care Ltd.?
NiveshIQ detects active intelligence signals for Procter & Gamble Hygiene & Health Care Ltd. (PGHH) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Procter & Gamble Hygiene & Health Care Ltd.?
Procter & Gamble Hygiene & Health Care Ltd. operates in the Healthcare sector with a market capitalisation of ₹2,751,696.7L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.